Skip to main content
3-D Matrix,Ltd. logo

3-D Matrix,Ltd. — Investor Relations & Filings

Ticker · 7777 ISIN · JP3410730000 T Manufacturing
Open in API
Filings indexed 71 across all filing types
Latest filing 2026-05-29 Board/Management Inform…
Country JP Japan
Listing T 7777

About 3-D Matrix,Ltd.

https://3dmatrix.com/

3-D Matrix, Ltd. is a global medical technology company specializing in the development and commercialization of products based on a proprietary self-assembling peptide technology. Originating from research at the Massachusetts Institute of Technology (MIT), this platform creates biocompatible hydrogels used primarily as hemostatic agents to control oozing bleeding during surgical and endoscopic procedures. The company's solutions are applied across various medical specialties, including gastroenterology, cardiac surgery, otolaryngology (ENT), and urology. 3-D Matrix is also advancing its peptide platform to develop new applications in wound healing, regenerative medicine, and drug delivery systems, aiming to provide clinically proven solutions that improve patient outcomes.

Recent filings

Filing Released Lang Actions
取締役の辞任に関するお知らせ
Board/Management Information Classification · 96% confidence The document is a brief announcement notifying the resignation of a company director, which directly corresponds to a board/management change. It is not an AGM material, financial report, or regulatory attestation. As it announces a director’s resignation, it falls under Board/Management Information.
2026-05-29 Japanese
業績予想の修正及び営業外収益の計上に関するお知らせ
Regulatory Filings Classification · 45% confidence The document is a Japanese regulatory disclosure titled “業績予想の修正及び営業外収益の計上に関するお知らせ” (Notice of revision to earnings forecast and recognition of non-operating income). It presents revised full-year forecasts, percentage changes versus prior forecasts, and explanatory notes—without containing actual financial statements or full periodic results. It is not an interim or annual report (IR/10-K), nor is it an earnings release of actual results (ER), call transcript, board change, capital event, or similar. It is a standalone regulatory announcement of a forecast revision, best classified under the general Regulatory Filings category (RNS).
2026-05-19 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It specifically confirms the accuracy of the contents of a Semi-Annual Report (Hankishokokusho) for the period ending October 31, 2025. Since this is a regulatory filing confirming the accuracy of financial reporting and does not fit into the specific categories of the reports themselves (like 10-K or IR), it falls under the general regulatory filing category.
2025-12-11 Japanese
半期報告書－第22期(2025/05/01－2026/04/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, management analysis, and business information for the interim period (2025-05-01 to 2025-10-31). This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2026
2025-12-11 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. It serves as a formal certification by the CEO/CFO regarding the accuracy of the company's Annual Securities Report (Yuuka Shouken Houkokusho). Since it is a regulatory filing required by law to accompany the annual report but is not the annual report itself, and does not fit into specific categories like 'RPA' or '10-K', it falls under the general regulatory filing category. FY 2025
2025-07-24 Japanese
有価証券報告書－第21期(2024/05/01－2025/04/30)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, management discussion, and corporate information for the fiscal year ending April 30, 2025. The header explicitly identifies it as a 'Securities Report' (有価証券報告書) submitted under the Financial Instruments and Exchange Act. FY 2025
2025-07-24 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.